tiprankstipranks
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
US Market

Newron Pharmaceuticals SpA (NWPHF) Income Statement

Compare
9 Followers

Newron Pharmaceuticals SpA Income Statement

Last quarter (Q2 2024), Newron Pharmaceuticals SpA's total revenue was €3.41M, an increase of 20.39% from the same quarter last year. In Q2, Newron Pharmaceuticals SpA's net income was €-9.56M. See Newron Pharmaceuticals SpA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 9.06M€ 6.09M€ 5.76M€ 5.26M€ 7.04M
Gross Profit
€ 9.06M€ 6.09M€ 5.76M€ 4.96M€ 5.61M
Operating Expenses
€ 20.69M€ 19.68M€ 17.78M€ 22.70M€ 26.82M
Depreciation and Amortization
€ 201.00K€ 202.00K€ 209.00K€ 219.00K€ 206.00K
EBITDA
€ -11.83M€ -13.32M€ -12.31M€ -17.99M€ -20.85M
Operating Income
€ -11.63M€ -13.30M€ -12.36M€ -18.07M€ -20.90M
Other Income/Expenses
€ -4.57M€ -4.17M€ -2.53M€ -1.55M€ 737.00K
Pretax Income
€ -16.20M€ -17.47M€ -14.88M€ -19.62M€ -20.16M
Net Income
€ -16.22M€ -17.49M€ -14.90M€ -21.00M€ -20.21M
Per Share Metrics
Basic EPS
€ -0.91€ -0.98€ -0.84€ -1.18€ -1.13
Diluted EPS
€ -0.91€ -0.98€ -0.84€ -1.18€ -1.13
Weighted Average Shares Outstanding
17.85M 17.84M 17.84M 17.84M 17.84M
Weighted Average Shares Outstanding (Diluted)
17.84M 17.84M 17.84M 17.84M 17.84M
Currency in EUR

Newron Pharmaceuticals SpA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis